Acceleron Pharma
Accelerating drug discovery to transform patients' lives
67 employees · est. 2003 · Cambridge, United States
Atea Pharmaceuticals, Inc
Discovery & development of breakthrough therapies for COVID-19 patients and severe viral diseases
58 employees · est. 2014 · Boston, United States
Acceleron Pharma is the older company (2003 vs 2014).
Side-by-Side Comparison
| Metric | Acceleron Pharma | Atea Pharmaceuticals, Inc |
|---|---|---|
| Founded | ||
| Founded | 2003 older | 2014 |
| Headquarters | ||
| Headquarters | Cambridge, United States | Boston, United States |
| Employees | ||
| Employees | 67 | 58 |
| Industry | ||
| Industry | Biotechnology, Health Care, Manufacturing | Biopharma, Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Post Ipo Equity | IPO |
| Total Funding | ||
| Total Funding | Not tracked yet | $283.40M |
| Funding Rounds | ||
| Funding Rounds | 15 | 5 |
| Services | ||
| Services | Not tracked yet | discovery and development of oral antiviral therapies, development of treatments for ssRNA viruses, clinical trials for hepatitis C virus therapies |
| Target Customers | ||
| Target Customers | Not tracked yet | patients with serious viral diseases, healthcare providers treating hepatitis C, pharmaceutical companies seeking novel antiviral solutions |
| Taxonomy | ||
| Taxonomy | Biopharmaceuticals, Orphan Disease Therapeutics, Rare Diseases, Musculoskeletal Diseases, Cancer Therapeutics, Metabolic Disorders, Muscle Loss Therapies, Neuromuscular Diseases, Angiogenesis Therapies, Drug Discovery, Biotherapeutics, Cellular Proliferation, Differentiation Factors, Tissue Regeneration, Clinical Research | Biopharmaceutical, Clinical-stage, Antiviral Therapeutics, RNA Viruses, DNA Viruses, Breakthrough Therapies, COVID-19 Therapies, Severe Viral Diseases, Novel Antimicrobial Treatment, Therapeutics Discovery, Viral Infections, Unmet Medical Needs, Next-generation Therapeutics |
| Website | ||
| Website | acceleronpharma.com | ateapharma.com |
About Acceleron Pharma
Acceleron Pharma is a biotechnology company founded in 2003 with a clear vision encapsulated in their slogan, "Accelerating drug discovery to transform patients' lives." On November 22, 2021, the company underwent a significant change as it became a wholly-owned subsidiary of Merck & Co., Inc. This...
About Atea Pharmaceuticals, Inc
Atea Pharmaceuticals, Inc., founded in 2014, is a promising player in the biopharmaceutical landscape. Amid growing global health crises, the company focuses on the discovery & development of breakthrough therapies, particularly targeting COVID-19 patients and other severe viral diseases. This posit...
We will tell you when either one moves
BounceWatch watches Acceleron Pharma and Atea Pharmaceuticals, Inc for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Acceleron Pharma and Atea Pharmaceuticals,... — by email.
Frequently Asked Questions
Compare Acceleron Pharma with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Acceleron Pharma on 3 Dec 2024, and Atea Pharmaceuticals, Inc on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
